October 10, 2024 4:15 PM EDT | Source: Aion Therapeutic Inc.
On October 10, 2024, Aion Therapeutic Inc. (CSE: AION) provided an update on the management cease trade order (MCTO) issued by the British Columbia Securities Commission (BCSC) on August 29, 2024. The Company previously announced on August 14, 2024, that it would be unable to file its annual audited consolidated financial statements by the filing deadline of August 28, 2024, leading to the delay in filing the Required Documents.
Due to the ongoing process related to the acquisition of Toppen Health, Inc. on December 15, 2023, the Company has until October 28, 2024, to complete its Annual Filings. Aion Therapeutic confirms that, other than the information disclosed in the Default Announcement, there have been no material changes, specified defaults, insolvency proceedings, or undisclosed material information concerning the Company.
Aion Therapeutic is a progressive company in the health and wellness sector, focused on innovation and transformative solutions to redefine health and wellness boundaries. It owns Toppen, a US-based subsidiary dedicated to providing advanced water filtration solutions that are innovative, affordable, and sustainable.
This release contains forward-looking information regarding the Company’s business goals, management’s expectations, and the preparation and timing of filing Required Documents. Readers are advised to exercise caution when relying on such information, as it is inherently uncertain.
The securities of the Company have not been registered under the United States Securities Act of 1933, and this release does not constitute an offer to sell or solicitation to buy any securities. The Canadian Securities Exchange has not approved or disapproved the content of this press release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226200
